Allogeneic hematopoietic stem cell transplantation for B-cell lymphoma in Taiwan

Keyphrases

• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 100%
• B-cell Lymphoma 100%
• Complete Remission 10%
• Diffuse Large B-cell Lymphoma (DLBCL) 10%
• Follow-up Data 10%
• Follow-up Interval 10%
• Graft-versus-host Disease (GvHD) 20%
• High Risk 20%
• Marrow Transplantation 10%
• Multivariable 10%
• Non-relapse Mortality 10%
• Overall Survival 40%
• Progression-free Survival 10%
• Relapsed Disease 20%
• Relapsed or Refractory 10%
• Remission 10%
• Retrospective Observational Study 10%
• Taiwan 100%
• Therapeutic Potential 10%
• Transplantation 10%

Medicine and Dentistry

• Allogeneic Hematopoietic Stem Cell Transplantation 100%
• Autologous Stem Cell Transplantation 25%
• B-Cell Lymphoma 100%
• Diffuse Large B-Cell Lymphoma 12%
• Diseases 25%
• Graft Versus Host Reaction 25%
• Infection 12%
• Non-Relapse Mortality 12%
• Observational Study 12%
• Overall Survival 50%
• Progression Free Survival 12%

Immunology and Microbiology

• Allogeneic Hematopoietic Stem Cell Transplantation 100%
• Autologous Stem Cell Transplantation 25%
• B Cell 100%
• Graft-Versus-Host Disease 25%
• Overall Survival 50%
• Progression Free Survival 12%